Columbus Macro’s Celgene Corp CELG Stock Holding History

Columbus Macro’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,765	Closed	-$572K	–	183
2019 Q3	$572K	Sell	5,765 -1,367	-19%	-$130K	0.14%	89
2019 Q2	$659K	Sell	7,132 -447	-6%	-$42.4K	0.14%	92
2019 Q1	$715K	Sell	7,579 -334	-4%	-$29.2K	0.16%	80
2018 Q4	$507K	Buy	+7,913	New	+$584K	0.12%	106
2018 Q3	–	Sell	-4,719	Closed	-$375K	–	130
2018 Q2	$375K	Buy	4,719 +43	+0.9%	+$3.57K	0.1%	113
2018 Q1	$417K	Buy	4,676 +37	+0.8%	+$3.55K	0.11%	99
2017 Q4	$484K	Buy	+4,639	New	+$523K	0.15%	85

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Columbus Macro's CELG Position: Q4 2019 in Review

Columbus Macro sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,765 shares — an estimated $572K sold.

Columbus Macro first reported a position in CELG in Q4 2017 and held it in 7 quarters. The position peaked at $715K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Columbus Macro reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Columbus Macro sold 5,765 Celgene Corp shares in Q4 2019, an estimated $572K.
Columbus Macro first reported a position in Celgene Corp in Q4 2017 and held it in 7 quarters.
Columbus Macro's Celgene Corp position peaked at $715K in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Columbus Macro's 13F filing for Q4 2019, filed 27 Jan 2020.